Literature DB >> 12374280

Histone acetyltransferases and deacetylases in the control of cell proliferation and differentiation.

Heike Lehrmann1, Linda Louise Pritchard, Annick Harel-Bellan.   

Abstract

Histone acetylation and deacetylation are chromatin-modifying processes that have fundamental importance for transcriptional regulation. Transcriptionally active chromatin regions show a high degree of histone acetylation, whereas deacetylation events are generally linked to transcriptional silencing. Many of the acetylating and deacetylating enzymes were originally identified as transcriptional coactivators or repressors. Their histone-modifying enzymatic activity was discovered more recently, opening up a whole new area of research. Histone acetyltransferases such as CREB-binding protein (CBP) and PCAF are involved in processes as diverse as promoting cell cycle progression and regulating differentiation. A controlled balance between histone acetylation and deacetylation seems to be essential for normal cell growth. Both histone acetyltransferases and deacetylases are involved in the development of diseases, including neurodegenerative disorders and cancer. Treatments that target these enzymes are already under clinical investigation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12374280     DOI: 10.1016/s0065-230x(02)86002-x

Source DB:  PubMed          Journal:  Adv Cancer Res        ISSN: 0065-230X            Impact factor:   6.242


  56 in total

1.  Interaction and functional cooperation between the LIM protein FHL2, CBP/p300, and beta-catenin.

Authors:  Charlotte Labalette; Claire-Angélique Renard; Christine Neuveut; Marie-Annick Buendia; Yu Wei
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

2.  HDAC6 is a specific deacetylase of peroxiredoxins and is involved in redox regulation.

Authors:  R B Parmigiani; W S Xu; G Venta-Perez; H Erdjument-Bromage; M Yaneva; P Tempst; P A Marks
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-07       Impact factor: 11.205

Review 3.  Epigenetic changes in the myelodysplastic syndrome.

Authors:  Jean-Pierre Issa
Journal:  Hematol Oncol Clin North Am       Date:  2010-04       Impact factor: 3.722

4.  Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge.

Authors:  Natalie Fischer; Emmanuel Sechet; Robin Friedman; Aurélien Amiot; Iradj Sobhani; Giulia Nigro; Philippe J Sansonetti; Brice Sperandio
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-09       Impact factor: 11.205

5.  A phase 1 trial of Vorinostat in combination with concurrent chemoradiation therapy in the treatment of advanced staged head and neck squamous cell carcinoma.

Authors:  Theodoros N Teknos; J Grecula; A Agrawal; M O Old; E Ozer; R Carrau; S Kang; J Rocco; D Blakaj; V Diavolitsis; B Kumar; P Kumar; Q Pan; M Palettas; L Wei; R Baiocchi; P Savvides
Journal:  Invest New Drugs       Date:  2018-12-19       Impact factor: 3.850

Review 6.  Diabetic embryopathy: a role for the epigenome?

Authors:  J Michael Salbaum; Claudia Kappen
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2011-05-02

7.  The synthesis and evaluation of N1-(4-(2-[18F]-fluoroethyl)phenyl)-N8-hydroxyoctanediamide ([18F]-FESAHA), a PET radiotracer designed for the delineation of histone deacetylase expression in cancer.

Authors:  Brian M Zeglis; NagaVaraKishore Pillarsetty; Vadim Divilov; Ronald A Blasberg; Jason S Lewis
Journal:  Nucl Med Biol       Date:  2011-03-03       Impact factor: 2.408

8.  Characterization of the regulation and function of zinc-dependent histone deacetylases during rodent liver regeneration.

Authors:  Jiansheng Huang; Emily Barr; David A Rudnick
Journal:  Hepatology       Date:  2013-05       Impact factor: 17.425

9.  Expression profile of CREB knockdown in myeloid leukemia cells.

Authors:  Matteo Pellegrini; Jerry C Cheng; Jon Voutila; Dejah Judelson; Julie Taylor; Stanley F Nelson; Kathleen M Sakamoto
Journal:  BMC Cancer       Date:  2008-09-18       Impact factor: 4.430

10.  Transcriptional regulation of human osteopontin promoter by histone deacetylase inhibitor, trichostatin A in cervical cancer cells.

Authors:  Priyanka Sharma; Santosh Kumar; Gopal C Kundu
Journal:  Mol Cancer       Date:  2010-07-07       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.